TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27483995

Group type: EXPERIMENTAL
Intervention: Hospital outreach rehabilitation program
Number of subjects: 28

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study: 24332259

Group type: EXPERIMENTAL
Intervention: Supervised exercise program (6 weeks duration)
Number of subjects: 20
Study: 22730816

Group type: EXPERIMENTAL
Intervention: Nebulized budesonide suspension (1 mg twice daily) via transnasal inhalation for one week
Number of subjects: 30

Group type: COMPARATOR
Intervention: Budesonide nasal spray (256 microg twice daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nebulized budesonide
Number of subjects: 30
Study: 20932512

Group type: EXPERIMENTAL
Intervention: Parent Training (PT) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study: 18470602

Group type: EXPERIMENTAL
Intervention: Right ventricular apex (RVA)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Right ventricular outflow tract (RVOT)
Number of subjects: 26
Study: 15847949

Group type: EXPERIMENTAL
Intervention: Gentamycin (GM) eardrops
Number of subjects: 95

Group type: COMPARATOR
Intervention: Gentamycin-steroid combination (GM-S) eardrops
Number of subjects: 95
Study: 12563493

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sulfadoxine/pyrimethamine (SP)
Number of subjects: 0
Study: 10326918

Group type: EXPERIMENTAL
Intervention: Semirigid orthotics
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nonorthotic condition
Number of subjects: 12
Study: 7841356

Group type: EXPERIMENTAL
Intervention: Iron supplementation (ferrous sulphate drops: 3 mg/Kg/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Iron deficiency without anemia (ID)
Number of subjects: 36
Study: 3411737

Group type: EXPERIMENTAL
Intervention: Gum plus group (trained physicians)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Gum only group (physicians offered nicotine gum)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual care group (standard care)
Number of subjects: 70
Study: 29921730

Group type: EXPERIMENTAL
Intervention: CIMP+ patients
Number of subjects: 1907

Group type: COMPARATOR
Intervention: Cetuximab in CIMP+ tumors
Number of subjects: 1907
Study: 28679643

Group type: EXPERIMENTAL
Intervention: Intralesional GM‐CSF (500 mcg standard dose)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA) + GM‐CSF
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Cryoablation + GM‐CSF
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Induction of endogenous HSP70 and melanoma-specific cytotoxic T lymphocytes (CTL)
Number of subjects: 9
Study: 23852313

Group type: EXPERIMENTAL
Intervention: Continuous Theta Burst Stimulation (cTBS)
Number of subjects: 55

Group type: COMPARATOR
Intervention: High-frequency rTMS (10 Hz)
Number of subjects: 55
Study: 22751755

Group type: EXPERIMENTAL
Intervention: Pharmacist‐assisted medication reconciliation, inpatient pharmacist counseling, low‐literacy adherence aids, and individualized telephone follow‐up after discharge
Number of subjects: 851
Study: 20356582

Group type: EXPERIMENTAL
Intervention: Spontaneous cycle (n=10)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ovulation induction with clomiphene‐citrate (n=15)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ovulation induction with gonadotropins (n=9)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Controlled ovarian hyperstimulation for IVF (COH‐IVF; n=10)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Exogenous E2 for frozen‐thawed embryo‐transfer (FET; n=20)
Number of subjects: 64
Study: 18197095

Group type: EXPERIMENTAL
Intervention: FlexiCore
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control
Number of subjects: 67
Study: 16685822

Group type: EXPERIMENTAL
Intervention: SVM classification using the best set of features
Number of subjects: 61
Study: 12907530

Group type: EXPERIMENTAL
Intervention: Specific expiratory muscle training (SEMT), daily, six times a week, 1/2 hour per session for 3 months
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (very low load training)
Number of subjects: 26
Study: 10472466

Group type: EXPERIMENTAL
Intervention: Non-buffered saline solution
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Buffered saline solution (pH 8)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 30
Study: 8979657

Group type: EXPERIMENTAL
Intervention: Medication alarm device (TimeCap)
Number of subjects: 13

Group type: COMPARATOR
Intervention: No medication alarm device (Control)
Number of subjects: 13
Study: 1612814

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine (0.4 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular morphine (10 mg)
Number of subjects: 0
Study: 6378733

Group type: EXPERIMENTAL
Intervention: Antacids and/or anticholinergic drugs
Number of subjects: 75
Study: 31852902

Group type: EXPERIMENTAL
Intervention: Foster care intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 0

Group type: COMPARATOR
Intervention: Never-institutionalized children
Number of subjects: 0
Study: 29573330

Group type: EXPERIMENTAL
Intervention: Tinzaparin 175 IU kg-1 once daily
Number of subjects: 900

Group type: COMPARATOR
Intervention: Warfarin (target INR of 2.0-3.0)
Number of subjects: 900
Study: 26433207

Group type: EXPERIMENTAL
Intervention: Alanine aminotransferase levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alanine aminotransferase levels below reference range
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alanine aminotransferase levels above reference range
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gamma‐glutamyltransferase levels
Number of subjects: 0
Study: 24192009

Group type: EXPERIMENTAL
Intervention: Nurse support
Number of subjects: 461

Group type: COMPARATOR
Intervention: Education
Number of subjects: 461

Group type: COMPARATOR
Intervention: Enhanced care
Number of subjects: 461
Study: 22863206

Group type: EXPERIMENTAL
Intervention: Qigong training (level 1 Chaoyi Fanhuan Qigong, CFQ), given over three half‐days, followed by weekly review/practice sessions for eight weeks, with home practice for 45 to 60 minutes per day.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Wait-list/usual care control group
Number of subjects: 100
Study: 21058479

Group type: EXPERIMENTAL
Intervention: Combined therapy group of Four Points of Throat acupuncture and routine medication (group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine medication only (group 2)
Number of subjects: 60
Study: 18198327

Group type: EXPERIMENTAL
Intervention: School-based health promotion intervention including six nutrition units and 20-minute running games in the first year.
Number of subjects: 1764
Study: 15861018

Group type: EXPERIMENTAL
Intervention: omeprazole + amoxicillin with metronidazole
Number of subjects: 265

Group type: COMPARATOR
Intervention: omeprazole + amoxicillin with clarithromycin
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: omeprazole + amoxicillin with metronidazole (metronidazole-susceptible bacteria)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: omeprazole + amoxicillin with metronidazole (metronidazole-resistant bacteria)
Number of subjects: 265

Group type: COMPARATOR
Intervention: omeprazole + amoxicillin with clarithromycin (clarithromycin-sensitive strains)
Number of subjects: 265

Group type: COMPARATOR
Intervention: omeprazole + amoxicillin with clarithromycin (clarithromycin-resistant strains)
Number of subjects: 265
Study: 11967720

Group type: EXPERIMENTAL
Intervention: Placebo + Ang II infusion (A)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Valsartan + Ang II infusion (VA)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 9
Study: 9464723

Group type: EXPERIMENTAL
Intervention: Intravaginal PGE2 gel (2 mg)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Intracervical PGE2 gel (0.5 mg)
Number of subjects: 247
Study: 7796228

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin administration for prophylaxis
Number of subjects: 5245

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin administration for treatment
Number of subjects: 5245
Study: 2024814

Group type: EXPERIMENTAL
Intervention: Plugged telescoping catheter (PTC)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Protected specimen brush (PSB)
Number of subjects: 55
Study: 7008655

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 1 or 2 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 2 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lidocaine 2% (local perineal infiltration)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pudendal block
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epidural block
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 20
Study: 31792878

Group type: EXPERIMENTAL
Intervention: Morphine drops with ethanol (red morphine drops, RMD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine drops without ethanol
Number of subjects: 0
Study: 30366577

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (400 IU/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct UV light exposure
Number of subjects: 0
Study: 28091446

Group type: EXPERIMENTAL
Intervention: One-hour running (Group B)
Number of subjects: 3600

Group type: EXPERIMENTAL
Intervention: 90-minute running (Group C)
Number of subjects: 3600

Group type: COMPARATOR
Intervention: Half-hour running (Group A)
Number of subjects: 3600
Study: 26106113

Group type: EXPERIMENTAL
Intervention: Intravenous recombinant tissue-type plasminogen activator (IV r‐tPA)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control
Number of subjects: 106
Study: 23266331

Group type: EXPERIMENTAL
Intervention: Stretching exercise program (SEP)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Usual activities
Number of subjects: 127
Study: 22306962

Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise for 30 min
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (watched a running/exercise-related video)
Number of subjects: 40
Study: 21129341

Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring system (CGMS) with low glucose alarm set at 80 mg/dl for 3 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: No alarm condition
Number of subjects: 14
Study: 17418727

Group type: EXPERIMENTAL
Intervention: Plasma interleukin‐6 (IL‐6)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Plasma interleukin‐10 (IL‐10)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Fractional escape rate (FER) of Evans blue
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Colloid osmotic pressure (COP)
Number of subjects: 11
Study: 15883637

Group type: EXPERIMENTAL
Intervention: Alendronate (5 mg daily for 2 years, then 10 mg for 1-2.5 years)
Number of subjects: 3658
Study: 15603033

Group type: EXPERIMENTAL
Intervention: 50 microg misoprostol vaginal gel
Number of subjects: 238

Group type: COMPARATOR
Intervention: 5 mg of prostaglandin E2 gel
Number of subjects: 238
Study: 9481721

Group type: EXPERIMENTAL
Intervention: Continuous intravenous intradialysis rHuEpo therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intravenous postdialysis rHuEpo therapy (control)
Number of subjects: 20
Study: 7616279

Group type: EXPERIMENTAL
Intervention: Unicortical Caspar cervical plating screw
Number of subjects: 99

Group type: COMPARATOR
Intervention: Bicortical Caspar cervical plating screw
Number of subjects: 99
Study: 2575796

Group type: EXPERIMENTAL
Intervention: Pipothiazine palmitate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluphenazine decanoate
Number of subjects: 0
Study: 791537

Group type: EXPERIMENTAL
Intervention: Surgical treatment (one or more aortocoronary saphenous vein bypass grafts)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Medical treatment (conventional medical treatment)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 113

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 113
Study: 31880975

Group type: EXPERIMENTAL
Intervention: Combined oncologist-patient/caregiver intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study: 31407549

Group type: EXPERIMENTAL
Intervention: 20 mg/kg TXA administered intravenously before 5-10 minutes of operation (Group A)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 40 mg/kg TXA administered intravenously before 5-10 minutes of operation (Group B)
Number of subjects: 72
Study: 28697050

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (hemoglobin 7-8 g/dL)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Liberal transfusion strategy (hemoglobin 10-11 g/dL)
Number of subjects: 345
Study: 26673788

Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy with bevacizumab (BEV) in combination with cytoreductive surgery (CRS) and oxaliplatin-based intraperitoneal chemoperfusion (IPC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy with bevacizumab (BEV)
Number of subjects: 0
Study: 23531438

Group type: EXPERIMENTAL
Intervention: 2.5mg oral tibolone (n=11)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1.25mg oral tibolone (n=13)
Number of subjects: 24
Study: 22065593

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 70
Study: 19735620

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 3580

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 3580
Study: 17719314

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 9001

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 9001

Group type: COMPARATOR
Intervention: Atorvastatin (both dosages)
Number of subjects: 9001
Study: 15048740

Group type: EXPERIMENTAL
Intervention: Hand-assisted RYGBP
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open RYGBP
Number of subjects: 50
Study: 11356774

Group type: COMPARATOR
Intervention: multimodal exercise intervention
Number of subjects: 67
Study: 9040295

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 432

Group type: COMPARATOR
Intervention: Intravenous heparin
Number of subjects: 432
Study: 8250306

Group type: EXPERIMENTAL
Intervention: Sufentanil 10 micrograms plus epinephrine 200 micrograms
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Sufentanil 10 micrograms plus morphine 250 micrograms
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sufentanil 10 micrograms
Number of subjects: 41
Study: 3114189

Group type: EXPERIMENTAL
Intervention: Pion therapy
Number of subjects: 228
Study: 30106868

Group type: EXPERIMENTAL
Intervention: LifeFlow
Number of subjects: 54

Group type: COMPARATOR
Intervention: Pressure bag
Number of subjects: 54

Group type: COMPARATOR
Intervention: Push/pull
Number of subjects: 54
Study: 28424025

Group type: EXPERIMENTAL
Intervention: Selective reminding condition (SR)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Single trial encoding condition (1T)
Number of subjects: 21
Study: 29669567

Group type: EXPERIMENTAL
Intervention: HERrespect intervention involving gender transformative group-based training, joint sessions, factory-wide activities, awareness raising, policy review, and community campaigns.
Number of subjects: 1195

Group type: COMPARATOR
Intervention: Control factories (not specified in detail).
Number of subjects: 1195
Study: 27325599

Group type: EXPERIMENTAL
Intervention: Citrate dialysate
Number of subjects: 19

Group type: COMPARATOR
Intervention: Acetate dialysate
Number of subjects: 19
Study: 24320856

Group type: EXPERIMENTAL
Intervention: Ketamine alone
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Pregabalin alone
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Ketamine and pregabalin combined
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 142
Study: 21846677

Group type: EXPERIMENTAL
Intervention: Postconditioning (p-cond)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 79
Study: 20979675

Group type: EXPERIMENTAL
Intervention: Tai chi plus usual care
Number of subjects: 10

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 10
Study: 18568842

Group type: EXPERIMENTAL
Intervention: Computed tomographic scan analysis (various methods including automated densitometric analysis and visual grading by trained radiologists)
Number of subjects: 1094

Group type: EXPERIMENTAL
Intervention: Computed tomographic scan analysis
Number of subjects: 1094
Study: 15678301

Group type: EXPERIMENTAL
Intervention: Intraoperative monitoring methods (including duplex sonography, intraoperative angiograms, angioscopy, somatic evoked potentials, transcranial duplex sonography)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraoperative control methods in carotid surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality control of the peripheral vascular system
Number of subjects: 0
Study: 12658936

Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: 0.9% NS
Number of subjects: 70
Study: 10396321

Group type: EXPERIMENTAL
Intervention: 5'-DFUR (800 mg daily for 3 weeks)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 5'-DFUR
Number of subjects: 55
Study: 8839231

Group type: EXPERIMENTAL
Intervention: ITF 296
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2123819

Group type: EXPERIMENTAL
Intervention: Protein Hydrolysate (PH) diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-Degraded Protein (NDP) diet
Number of subjects: 12
Study: 6990948

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate with neostigmine
Number of subjects: 641

Group type: COMPARATOR
Intervention: Atropine with neostigmine
Number of subjects: 641
Study: 31651037

Group type: EXPERIMENTAL
Intervention: Psoralen and narrowband UVB (P-NBUVB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Narrowband UVB (NBUVB)
Number of subjects: 40
Study: 30782674

Group type: EXPERIMENTAL
Intervention: Families First Programme (10 group sessions and four home visits over 3 months)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Waitlist control group (standard community health and social services only)
Number of subjects: 720
Study: 28705728

Group type: EXPERIMENTAL
Intervention: Direct loading group A (n=81)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Conventional loading group B (n=77)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Both groups A and B
Number of subjects: 158
Study: 25945662

Group type: EXPERIMENTAL
Intervention: Slow diaphragmatic breathing (DB)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (breathing naturally at a normal pace)
Number of subjects: 43
Study: 23623841

Group type: EXPERIMENTAL
Intervention: Nordic walking (NW)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RT)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 144
Study: 21330285

Group type: EXPERIMENTAL
Intervention: Internet-based smoking cessation program
Number of subjects: 1112

Group type: COMPARATOR
Intervention: Booklet smoking cessation program
Number of subjects: 1112

Group type: EXPERIMENTAL
Intervention: Internet-based smoking cessation program (completed)
Number of subjects: 1112

Group type: EXPERIMENTAL
Intervention: Internet-based smoking cessation program (not completed)
Number of subjects: 1112
Study: 19095848

Group type: EXPERIMENTAL
Intervention: Video laryngoscope
Number of subjects: 44

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Comparison of laryngoscope types
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Mallampati and Cormack-Lehane grades
Number of subjects: 44
Study: 17167280

Group type: EXPERIMENTAL
Intervention: Statin treatment for primary and secondary prevention of CHD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholesterol synthesis inhibition in the brain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of biomarkers linked to fatal CHD events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changing lipid nutrition advice
Number of subjects: 0
Study: 15519288

Group type: EXPERIMENTAL
Intervention: OTC lovastatin 20 mg
Number of subjects: 3300
Study: 11302460

Group type: EXPERIMENTAL
Intervention: Cryotherapy (20 minute cold pack application to the calf)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 26
Study: 9663360

Group type: EXPERIMENTAL
Intervention: Domperidone 20 mg QID for 4 weeks
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 287

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 287
Study: 8092897

Group type: EXPERIMENTAL
Intervention: Selective vagotomy-antrectomy (SV-A)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Parietal cell vagotomy (PCV)
Number of subjects: 200
Study: 3134859

Group type: EXPERIMENTAL
Intervention: MQF-OK therapy with UFT (group B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: MQF-OK therapy with FT (group A)
Number of subjects: 80
Study: 31641534

Group type: EXPERIMENTAL
Intervention: AlterG device (LBPPSS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional treadmill gait training (TGT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: AlterG device (LBPPSS) in healthy controls (HC)
Number of subjects: 50
Study: 29931302

Group type: EXPERIMENTAL
Intervention: BBM e‐learning tool
Number of subjects: 79

Group type: COMPARATOR
Intervention: Traditional lecture
Number of subjects: 79
Study: 25849415

Group type: EXPERIMENTAL
Intervention: Single repetition group (SS of short duration <30 sec)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Multiple repetition group (SS of moderate duration)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control trial (no stretches performed)
Number of subjects: 40